Centro Integral Oncologico Clara Campal (Ciocc)

Madrid 28050

1 studies enrolling now · 5 studies all time

What they study most

Advanced Melanoma, Breast Cancer, Chronic Lymphocytic Leukemia, Locally Advanced Solid Tumors, Metastatic Solid Tumors, Non Hodgkin Lymphoma, Solid Tumor Malignancy

Studies at this site

• IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301) — Recruiting now
• A Study Evaluating Safety, PK, and Efficacy of Tafasitamab and Parsaclisib in Participants With Relapsed/Refractory Non Hodgkin Lymphoma (R/R NHL) or Chronic Lymphocytic Leukemia (CLL) — Stopped early
• A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer — Completed
• Efficacy and Safety of Pemigatinib in Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207) — Stopped early
• A Phase 1 Study of INCMGA00012 in Patients With Advanced Solid Tumors — Completed